Tres Cantos Open Lab : celebrating a decade of innovation in collaboration to combat endemic infectious diseases
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Nature reviews. Drug discovery - 20(2021), 11 vom: 01. Nov., Seite 799-800 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Calderón, Felix [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 07.12.2021 Date Revised 14.12.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1038/d41573-021-00143-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330138103 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330138103 | ||
| 003 | DE-627 | ||
| 005 | 20231225210638.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/d41573-021-00143-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1100.xml |
| 035 | |a (DE-627)NLM330138103 | ||
| 035 | |a (NLM)34471283 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Calderón, Felix |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tres Cantos Open Lab |b celebrating a decade of innovation in collaboration to combat endemic infectious diseases |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.12.2021 | ||
| 500 | |a Date Revised 14.12.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a News | |
| 700 | 1 | |a Ballell, Lluis |e verfasserin |4 aut | |
| 700 | 1 | |a Barros, David |e verfasserin |4 aut | |
| 700 | 1 | |a Bilbe, Graeme |e verfasserin |4 aut | |
| 700 | 1 | |a Cammack, Nicholas |e verfasserin |4 aut | |
| 700 | 1 | |a Gabarró, Raquel |e verfasserin |4 aut | |
| 700 | 1 | |a Halsey, Audra |e verfasserin |4 aut | |
| 700 | 1 | |a Heaton, Penny M |e verfasserin |4 aut | |
| 700 | 1 | |a Kang, Gagandeep |e verfasserin |4 aut | |
| 700 | 1 | |a Mizrahi, Valerie |e verfasserin |4 aut | |
| 700 | 1 | |a Nathan, Carl |e verfasserin |4 aut | |
| 700 | 1 | |a Strange, Mike E |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Pauline M |e verfasserin |4 aut | |
| 700 | 1 | |a Winzeler, Elizabeth A |e verfasserin |4 aut | |
| 700 | 1 | |a Fairlamb, Alan H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature reviews. Drug discovery |d 2002 |g 20(2021), 11 vom: 01. Nov., Seite 799-800 |w (DE-627)NLM119883511 |x 1474-1784 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2021 |g number:11 |g day:01 |g month:11 |g pages:799-800 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/d41573-021-00143-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2021 |e 11 |b 01 |c 11 |h 799-800 | ||